April 13, 2026 |
Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success.

Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success – including market analysis, sales teams, MSLs, training, launch meeting support, congress experiences, and product value demonstration.  Â
Our client is a US biotechnology company that specializes in developing therapies for complex and chronic conditions. For many years, the firm has been working on what’s become the first new FDA-approved therapy of its kind in almost two decades. Â
Our client’s landmark product is an easy-to-use therapy that allows for rapid absorption and targets various receptors. In clinical trials, the treatment was shown to significantly reduce pain.Â
Primarily, the client needed a commercialization partner to rapidly set up a large, flexible nationwide sales team ready for the product launch in October 2025.Â
Read the full case study here.
This content was provided by Inizio
Latest Content from Inizio
How will COVID-19 affect uptake of vaccinations against other diseases?
Living With Chronic Illness (Series one)
China: How pharma can maximize success in this rapidly changing emerging market
Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma
Migraine market snapshot
Monitoring the impact of COVID-19 on the market access landscape
Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19
UX research
In a recent interview with PME Magazine, Dan Coffin, Director explains why the application of behavioural science will be key to better health far beyond COVID-19.Read the full article here:…
Using qualitative conjoint to assess willingness-to-pay
